BackMaxCyte Overview

MaxCyte Long-Term Investments

MaxCyte's long-term investments is $36M.

Get informed when a big investor buys or sells

+ Follow
Long-Term Investments
$36.23M
↓ 6.13% YoYΔ $-2.37M vs prior year quarter

Peer trimmed avg / median

Loading

MaxCyte Long-Term Investments History

Loading

MaxCyte vs. peers: Long-Term Investments Comparison

Loading

MaxCyte Long-Term Investments Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

MaxCyte (MXCT) FAQ

The latest long-term investments for MXCT is $36M as of June 2026. That compares with $39M in the prior-year period — down 6.1% year over year. Investors often review this figure alongside MaxCyte's historical trend and sector peers before judging valuation or financial health.

Over the past year, MXCT's long-term investments moved from $39M to $36M — a 6.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in MaxCyte's operating scale or balance-sheet position.

A long-term investments figure of $36M for MXCT is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting MXCT's long-term investments ($36M), review year-over-year change from $39M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack MaxCyte's long-term investments against similar Materials names. You can also browse sector and industry screens on Stockcircle for a broader set of Materials companies and their key multiples and fundamentals.